MedTrace Logo

Enhanced Recovery After Surgery in Oblique Lumbar Interbody Fusion

NCT05959343 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2024-04-19

No results posted yet for this study

Summary

This study is a randomized controlled non-inferiority trial designed to evaluate the impact of implementing the 'Early Recovery After Surgery Clinical Pathway (ERAS CP)' on patient-reported pain levels at the time of discharge following Oblique Lumbar Interbody Fusion (OLIF) surgery

Conditions

  • Enhanced Recovery After Surgery
  • Spinal Fusion
  • Lumbar Spinal Stenosis
  • Lumbar Spondylolisthesis

Interventions

BEHAVIORAL

Enhanced Recovery After Surgery program for Oblique Lumbar Interbody Fusion

In the ERAS CP group, the components of the ERAS are protocolized and implemented as a clinical pathway

Sponsors & Collaborators

  • Medical Research Collaborating Center, Seoul, Korea

    collaborator OTHER

  • Armed Forces Capital Hospital, Republic of Korea

    collaborator OTHER_GOV

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chi Heon Kim, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-12
Primary Completion
2024-01-30
Completion
2024-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959343 on ClinicalTrials.gov